首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Toxicity of a Novel Herbomineral Preparation Las01 on Human Cancer Cell Lines and Its Safety Profile in Humans and Animals
【2h】

Toxicity of a Novel Herbomineral Preparation Las01 on Human Cancer Cell Lines and Its Safety Profile in Humans and Animals

机译:新型中草药制剂Las01对人癌细胞的毒性及其在人和动物中的安全性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Polyhedral formulations based on Rasayana therapy described in Charaka Samhita showed remarkable improvement in quality of life of various cancer patients who have been found to be refractory or poor responders to modern chemotherapy and radiation treatment. One of the most recent novel herbomineral preparation, Las01 prepared absolutely as per the instruction given in the ancient Ayurvedic literature has been found to be effective as a potent anticancer drug in the human cell lines, the MCF-7 and Hela cancer cell lines. This novel preparation of Las01 is also found to be devoid of toxicity both in animals as well as in human subjects, which is the main drawback of chemotherapeutic agents used in modern system of medicine. Our results warrant multicentric clinical trials on a large scale which seems to be a future promising drug to cure incurables cancer patients.
机译:Charaka Samhita中描述的基于Rasayana治疗的多面体制剂显示出各种癌症患者生活质量的显着改善,这些患者被发现对现代化学疗法和放射治疗无效或反应不良。 Las01是一种最新的新型人体矿物质制剂,完全按照古代阿育吠陀文献中的说明进行制备,已被发现可作为有效的抗癌药用于人类细胞系,MCF-7和Hela癌细胞系。还发现这种新颖的Las01制剂在动物和人类受试者中均无毒性,这是现代医学系统中使用的化学治疗剂的主要缺点。我们的结果值得进行大规模的多中心临床试验,这似乎是治疗无法治愈的癌症患者的有前途的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号